Anagliptin, a dipeptidyl peptidase‐4 inhibitor, improved bladder function and hemodynamics in rats with bilateral internal iliac artery ligation.

MLA

Hotta, Yuji, et al. “Anagliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Improved Bladder Function and Hemodynamics in Rats with Bilateral Internal Iliac Artery Ligation.” Neurourology & Urodynamics, vol. 39, no. 7, Sept. 2020, pp. 1922–29. EBSCOhost, https://doi.org/10.1002/nau.24449.

APA

Hotta, Y., Takahashi, S., Tokoro, M., Naiki, I. A., Maeda, K., Kawata, R., Kataoka, T., Ohta, Y., Hamakawa, T., Takahashi, S., Yasui, T., & Kimura, K. (2020). Anagliptin, a dipeptidyl peptidase‐4 inhibitor, improved bladder function and hemodynamics in rats with bilateral internal iliac artery ligation. Neurourology & Urodynamics, 39(7), 1922–1929. https://doi.org/10.1002/nau.24449

Chicago

Hotta, Yuji, Sena Takahashi, Misato Tokoro, Ito, Aya Naiki, Kotomi Maeda, Ryoya Kawata, Tomoya Kataoka, et al. 2020. “Anagliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Improved Bladder Function and Hemodynamics in Rats with Bilateral Internal Iliac Artery Ligation.” Neurourology & Urodynamics 39 (7): 1922–29. doi:10.1002/nau.24449.